Identification of Symtuza:
No description |
Search images on Google Product Monograph
Active Ingredients:
- darunavir (darunavir ethanolate), 800 MG
- cobicistat, 150 MG
- emtricitabine, 200 MG
- tenofovir alafenamide (tenofovir alafenamide hemifumarate), 10 MG
DIN: 02473720
Dosage Form(s): TABLET
Route(s) of Administration: ORAL
Schedule: Prescription
Company: JANSSEN INC – official site
ATC:
- J05 - ANTIVIRALS FOR SYSTEMIC USE (ATC, WHO, Wiki)
- J05A - DIRECT ACTING ANTIVIRALS (ATC, WHO)
- J05AR - Antivirals for treatment of HIV infections, combinations (ATC, WHO)
- J05AR22 - EMTRICITABINE, TENOFOVIR ALAFENAMIDE, DARUNAVIR AND COBICISTAT (WHO)
Packaging:
- Package size unit: No information
- Package type: No information
- Package size: No information
- Product information: 30
Pharmaceutical standard: USP
External Links for Symtuza:
Search on Google
- Symtuza side effects
- Symtuza dosage
- darunavir side effects
- darunavir dosage
- cobicistat side effects
- cobicistat dosage
- emtricitabine side effects
- emtricitabine dosage
- tenofovir alafenamide side effects
- tenofovir alafenamide dosage
Janssen Inc
Go to Janssen website to see drug product details. Sometimes you can find symtuza photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.